The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies

The Immuno-Oncology Translational Network (IOTN) was established in 2018 as part of the Cancer Moonshot. In 2022, President Joe Biden set new goals to reduce the cancer death rate by half within 25 years and improve the lives of people with cancer and cancer survivors. The IOTN is focused on acceler...

Descripción completa

Detalles Bibliográficos
Autores principales: Annapragada, Ananth, Sikora, Andrew G, Marathe, Himangi, Liu, Song, Demetriou, Michael, Fong, Lawrence, Gao, Jinming, Kufe, Donald, Morris, Zachary S, Vilar, Eduardo, Sharon, Elad, Hutson, Alan, Odunsi, Kunle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637038/
https://www.ncbi.nlm.nih.gov/pubmed/37572314
http://dx.doi.org/10.1093/jnci/djad151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637038/
https://www.ncbi.nlm.nih.gov/pubmed/37572314
http://dx.doi.org/10.1093/jnci/djad151

Ejemplares similares